Azithromycin: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
No edit summary
m (Text replacement - "United States" to "United States of America")
Line 3: Line 3:


==Development==
==Development==
Azithromycin was [[patent]]ed in 1982.<ref name="urlpatent:4328334 - Google Patents">{{cite web |url=http://www.google.com/patents?q=patent:4328334 |title=patent:4328334 - Google Patents |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.<ref name="urlDrugs@FDA">{{cite web |url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=ZITHROMAX |title=Drugs@FDA |author= |authorlink= |coauthors= |date= |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> Non-authorized [[generic drug]]s manufactured by [http://www.tevapharm.com/ Teva], [http://www.sandoz.com/ Sandoz], and Abraxis were approved in the [[United States]] starting in 2005.<ref name="urlDrugs@FDA">{{cite web |url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=azithromycin |title=Drugs@FDA |author= |authorlink= |coauthors= |date= |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref>
Azithromycin was [[patent]]ed in 1982.<ref name="urlpatent:4328334 - Google Patents">{{cite web |url=http://www.google.com/patents?q=patent:4328334 |title=patent:4328334 - Google Patents |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.<ref name="urlDrugs@FDA">{{cite web |url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=ZITHROMAX |title=Drugs@FDA |author= |authorlink= |coauthors= |date= |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref> Non-authorized [[generic drug]]s manufactured by [http://www.tevapharm.com/ Teva], [http://www.sandoz.com/ Sandoz], and Abraxis were approved in the [[United States of America]] starting in 2005.<ref name="urlDrugs@FDA">{{cite web |url=http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Overview&DrugName=azithromycin |title=Drugs@FDA |author= |authorlink= |coauthors= |date= |format= |work= |publisher=Food and Drug Administration |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=2009-02-01}}</ref>


==Drug toxicity==
==Drug toxicity==

Revision as of 11:54, 2 February 2023

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, azithromycin is a "semi-synthetic macrolide antibiotic structurally related to erythromycin. It has been used in the treatment of Mycobacterium avium intracellular infections, toxoplasmosis, and cryptosporidiosis."[1]

Development

Azithromycin was patented in 1982.[2] Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.[3] Non-authorized generic drugs manufactured by Teva, Sandoz, and Abraxis were approved in the United States of America starting in 2005.[3]

Drug toxicity

Drug toxicity includes cardiovascular death.[4]

References

  1. Anonymous (2024), Azithromycin (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. patent:4328334 - Google Patents. Retrieved on 2009-02-01.
  3. 3.0 3.1 Drugs@FDA. Food and Drug Administration. Retrieved on 2009-02-01. Cite error: Invalid <ref> tag; name "urlDrugs@FDA" defined multiple times with different content
  4. Ray et al. (2012) Azithromycin and the Risk of Cardiovascular Death